Celldex Therapeutics Inc (CLDX)
41.06
-0.15
(-0.36%)
USD |
NASDAQ |
May 09, 16:00
41.07
+0.01
(+0.02%)
After-Hours: 20:00
Celldex Therapeutics Cash from Financing (TTM): 653.88M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 653.88M |
December 31, 2023 | 218.46M |
September 30, 2023 | 2.479M |
June 30, 2023 | 4.528M |
March 31, 2023 | 4.466M |
December 31, 2022 | 4.076M |
September 30, 2022 | 3.107M |
June 30, 2022 | 272.70M |
March 31, 2022 | 272.60M |
December 31, 2021 | 272.37M |
September 30, 2021 | 271.99M |
June 30, 2021 | 4.584M |
March 31, 2021 | 169.66M |
December 31, 2020 | 171.23M |
September 30, 2020 | 173.60M |
June 30, 2020 | 171.58M |
March 31, 2020 | 13.73M |
December 31, 2019 | 16.26M |
September 30, 2019 | 17.40M |
June 30, 2019 | 20.48M |
March 31, 2019 | 21.54M |
December 31, 2018 | 29.44M |
September 30, 2018 | 44.33M |
June 30, 2018 | 50.06M |
March 31, 2018 | 50.46M |
Date | Value |
---|---|
December 31, 2017 | 51.29M |
September 30, 2017 | 36.12M |
June 30, 2017 | 33.15M |
March 31, 2017 | 27.10M |
December 31, 2016 | 14.48M |
September 30, 2016 | 11.52M |
June 30, 2016 | 3.954M |
March 31, 2016 | 1.672M |
December 31, 2015 | 193.15M |
September 30, 2015 | 192.84M |
June 30, 2015 | 192.41M |
March 31, 2015 | 192.23M |
December 31, 2014 | 1.171M |
September 30, 2014 | 184.71M |
June 30, 2014 | 185.03M |
March 31, 2014 | 175.79M |
December 31, 2013 | 289.60M |
September 30, 2013 | 125.62M |
June 30, 2013 | 134.58M |
March 31, 2013 | 142.35M |
December 31, 2012 | 79.76M |
September 30, 2012 | 60.31M |
June 30, 2012 | 50.71M |
March 31, 2012 | 87.90M |
December 31, 2011 | 28.43M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.479M
Minimum
Sep 2023
653.88M
Maximum
Mar 2024
136.96M
Average
95.07M
Median
Cash from Financing (TTM) Benchmarks
ThermoGenesis Holdings Inc | 3.278M |
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |